Cite
Optimization of 2-Aminoquinazolin-4-(3 H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties.
MLA
Shin, Young Sup, et al. “Optimization of 2-Aminoquinazolin-4-(3 H)-One Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties.” Pharmaceuticals (14248247), vol. 15, no. 7, July 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/ph15070831.
APA
Shin, Y. S., Lee, J. Y., Jeon, S., Cho, J.-E., Myung, S., Jang, M. S., Kim, S., Song, J. H., Kim, H. R., Park, H., Jeong, L. S., & Park, C. M. (2022). Optimization of 2-Aminoquinazolin-4-(3 H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties. Pharmaceuticals (14248247), 15(7), N.PAG. https://doi.org/10.3390/ph15070831
Chicago
Shin, Young Sup, Jun Young Lee, Sangeun Jeon, Jung-Eun Cho, Subeen Myung, Min Seong Jang, Seungtaek Kim, et al. 2022. “Optimization of 2-Aminoquinazolin-4-(3 H)-One Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties.” Pharmaceuticals (14248247) 15 (7): N.PAG. doi:10.3390/ph15070831.